DK173932B1 - SDK-peptider, fremgangsmåde til deres fremstilling og terapeutisk præparat indeholdende disse - Google Patents

SDK-peptider, fremgangsmåde til deres fremstilling og terapeutisk præparat indeholdende disse Download PDF

Info

Publication number
DK173932B1
DK173932B1 DK199000626A DK62690A DK173932B1 DK 173932 B1 DK173932 B1 DK 173932B1 DK 199000626 A DK199000626 A DK 199000626A DK 62690 A DK62690 A DK 62690A DK 173932 B1 DK173932 B1 DK 173932B1
Authority
DK
Denmark
Prior art keywords
lys
ser
pro
asp
peptides
Prior art date
Application number
DK199000626A
Other languages
Danish (da)
English (en)
Other versions
DK62690D0 (da
DK62690A (da
Inventor
Josiane Thierry
Maryse Lenfant
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of DK62690D0 publication Critical patent/DK62690D0/da
Publication of DK62690A publication Critical patent/DK62690A/da
Application granted granted Critical
Publication of DK173932B1 publication Critical patent/DK173932B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK199000626A 1989-03-11 1990-03-09 SDK-peptider, fremgangsmåde til deres fremstilling og terapeutisk præparat indeholdende disse DK173932B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8905606 1989-03-11
GB898905606A GB8905606D0 (en) 1989-03-11 1989-03-11 Peptides

Publications (3)

Publication Number Publication Date
DK62690D0 DK62690D0 (da) 1990-03-09
DK62690A DK62690A (da) 1990-09-12
DK173932B1 true DK173932B1 (da) 2002-02-25

Family

ID=10653152

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199000626A DK173932B1 (da) 1989-03-11 1990-03-09 SDK-peptider, fremgangsmåde til deres fremstilling og terapeutisk præparat indeholdende disse

Country Status (32)

Country Link
US (1) US5112811A (fr)
JP (1) JPH0347197A (fr)
KR (1) KR0133850B1 (fr)
AR (1) AR245139A1 (fr)
AT (1) AT402822B (fr)
AU (1) AU631197B2 (fr)
BE (1) BE1003996A3 (fr)
CA (1) CA2011874C (fr)
CH (1) CH680666A5 (fr)
DE (1) DE4007605B4 (fr)
DK (1) DK173932B1 (fr)
ES (1) ES2023746A6 (fr)
FI (1) FI901196A0 (fr)
FR (2) FR2644065B1 (fr)
GB (2) GB8905606D0 (fr)
GR (1) GR1000344B (fr)
HK (1) HK95392A (fr)
IE (1) IE64762B1 (fr)
IN (1) IN173870B (fr)
IT (1) IT1240933B (fr)
LU (1) LU87696A1 (fr)
MA (1) MA21770A1 (fr)
MY (1) MY106274A (fr)
NL (1) NL194918C (fr)
NO (1) NO901129L (fr)
NZ (1) NZ232815A (fr)
OA (1) OA09197A (fr)
PT (1) PT93380B (fr)
SE (1) SE9000793L (fr)
SG (1) SG91892G (fr)
TN (1) TNSN90027A1 (fr)
ZA (1) ZA901718B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK31991D0 (da) * 1991-02-25 1991-02-25 Carlbiotech Ltd As Peptid og farmaceutisk praeparat indeholdende et saadant peptid
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
DE4224509C2 (de) * 1992-07-24 1995-04-20 Ruhenstroth Bauer Gerhard Prof Wirkstoff zur Hemmung der Proliferationsrate von Leberzellen
RU2302870C1 (ru) * 2006-06-22 2007-07-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Средство, обладающее геропротекторной активностью, и способ его получения

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US216088A (en) * 1879-06-03 Improvement in bale-ties
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
FR2565985B1 (fr) * 1984-06-19 1987-09-25 Rhone Poulenc Sante Nouvelles substances biologiquement actives obtenues a partir de la caseine bovine, leur procede de preparation et les compositions qui les contiennent
WO1986002381A1 (fr) * 1984-10-15 1986-04-24 Cetus Corporation Facteur de necrose de tumeurs humaines
FR2601678B1 (fr) * 1986-07-18 1989-11-24 Inst Nat Sante Rech Med Peptides comprenant la sequence seryl-aspartyl-lysyl-prolyle, procede pour l'extraction du tetrapeptide correspondant, et applications, notamment a la protection de la moelle osseuse au cours de traitements anticancereux par la chimiotherapie
FR2622587B1 (fr) * 1987-10-30 1990-12-21 Inst Vaisseaux Sang Peptide lysyl-arginyl-aspartyl-serine et ses applications en tant que medicament, notamment antithrombotique
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤

Also Published As

Publication number Publication date
DK62690D0 (da) 1990-03-09
SG91892G (en) 1992-12-04
FR2644065B1 (fr) 1994-10-07
KR0133850B1 (ko) 1998-04-21
NO901129D0 (no) 1990-03-09
FR2644065A1 (fr) 1990-09-14
KR900014426A (ko) 1990-10-23
PT93380A (pt) 1990-11-07
MY106274A (en) 1995-04-29
NL194918C (nl) 2003-07-04
MA21770A1 (fr) 1990-10-01
DK62690A (da) 1990-09-12
SE9000793L (sv) 1990-09-12
FR2644164A1 (fr) 1990-09-14
IN173870B (fr) 1994-07-30
CA2011874C (fr) 1998-07-21
TNSN90027A1 (fr) 1991-03-05
IE900850L (en) 1990-09-11
NZ232815A (en) 1992-06-25
GB8905606D0 (en) 1989-04-26
GR1000344B (el) 1992-06-25
GB2228937A (en) 1990-09-12
IT9019630A1 (it) 1991-09-09
AU631197B2 (en) 1992-11-19
CH680666A5 (en) 1992-10-15
AT402822B (de) 1997-09-25
DE4007605B4 (de) 2006-03-23
BE1003996A3 (fr) 1992-09-08
LU87696A1 (fr) 1990-07-24
DE4007605A1 (de) 1990-09-13
AU5117590A (en) 1990-09-13
US5112811A (en) 1992-05-12
OA09197A (fr) 1992-06-30
NL194918B (nl) 2003-03-03
AR245139A1 (es) 1993-12-30
IT1240933B (it) 1993-12-27
ATA53290A (de) 1997-01-15
GB2228937B (en) 1992-07-08
FI901196A0 (fi) 1990-03-09
JPH0347197A (ja) 1991-02-28
HK95392A (en) 1992-12-04
NO901129L (no) 1990-09-12
GR900100164A (en) 1990-07-31
ZA901718B (en) 1990-12-28
CA2011874A1 (fr) 1990-09-11
IT9019630A0 (it) 1990-03-09
GB9005069D0 (en) 1990-05-02
PT93380B (pt) 1997-01-31
SE9000793D0 (sv) 1990-03-06
IE64762B1 (en) 1995-09-06
ES2023746A6 (es) 1992-02-01
FR2644164B1 (fr) 1995-03-17
NL9000551A (nl) 1990-10-01

Similar Documents

Publication Publication Date Title
US4612365A (en) Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4910296A (en) Medicaments containing alpha 1 thymosin fragments and having an immunostimulant action, and fragments of alpha 1 thymosin
US4439425A (en) Peptide derivatives
US4470926A (en) Medicaments containing thymosin alpha 1 fragments and having an immunostimulant action, and fragments of thymosin alpha 1
AU2694400A (en) Novel cyclic tetrapeptide derivatives and use thereof as drugs
Wecker et al. Expression of MuLV GP71-like antigen in normal mouse spleen cells induced by antigenic stimulation
CZ390597A3 (cs) Peptidy a způsob jeich přípravy
JPH07507330A (ja) ポリペプチドのボンベシン拮抗物質
DK173932B1 (da) SDK-peptider, fremgangsmåde til deres fremstilling og terapeutisk præparat indeholdende disse
RU2249599C2 (ru) Циклопептиды, способ их получения и применение в качестве ингибиторов или активаторов антиогенеза
US5114926A (en) Tetrapeptide inhibiting the entry into cycle of hemopoietic stem cells processes for its preparation, and its uses
EP0348086A2 (fr) Peptides, leur emploi comme immuno-suppressifs et procédés pour leur préparation
EP0033384B1 (fr) Médicaments contenant des fragments de thymosine-alpha-1, leur activité immunostimulante, et fragments de thymosine-alpha-1
RU2473559C1 (ru) Пептид аземиопсин, избирательно взаимодействующий с никотиновыми холинорецепторами мышечного типа и пригодный для использования в качестве мышечного релаксанта в медицине и косметологии
IL93107A (en) Peptides that inhibit the maturation of T lymphocytes and the activity of macrophages, pharmaceutical preparations containing them, and the process for their preparation
EP0056594B1 (fr) Fragments de thymosine alpha-1 et compositions pharmaceutiques à action immunorégulatrice qui les contiennent
CN114213216B (zh) 一种没药烷型倍半萜类化合物及其制备方法与应用
JP2628082B2 (ja) 免疫抑制剤
DK171969B1 (da) Tetrapeptid, dets fremstilling og anvendelse
SU1011632A1 (ru) Декапептид, обладающий липотропной активностью
US5656601A (en) Acylated splenopentins, methods for their synthesis and their use
SK136596A3 (en) New opioid peptide analogs with mixed mu agonist/delta antagonist properties
SIEMION et al. Competition between tuftsin and HBV S‐protein sequences
GALASIK‐BARTOSZEK et al. [Hyp3]‐tuftsin ([Hyp3]‐TU) synthesis and biological activity
KOZONO et al. Cyclic peptides: XVII. Synthesis of AM‐toxin II by cyclization of linear tetradepsipeptide containing a dehydroalanine residue

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK